ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1525

Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA

Susan J. Bartlett1, Michelle Jones2 and Clifton Bingham III3, 1Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Anxiety, depression, Fatigue, rheumatoid arthritis (RA) and sleep

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Some view fatigue as resulting from disease activity, while others see it as a natural consequence of the pain, disability, and the emotional burden of living with RA. We explored how RA symptoms and impacts contribute to fatigue.

Methods:  Participants had MD-diagnosed RA, were receiving care at an academic arthritis clinic, and were enrolled in an observational study. All completed PROMIS measures of fatigue, mood (depression, anxiety), and symptoms/impacts (physical function [PF], sleep disturbance, pain interference, and participation in social roles and activities). Clinical RA indicators and self reports of exercise frequency we also obtained. Pearson correlation and multiple regression models were used to evaluate associations among variables.

Results:  Data are from the baseline visit of 177 RA patients who were mostly female (82%) and white (83%) with a mean (SD) age of 56 (13) years; 24% had ≤ high school, 29% had RA ≤ 5 years with 13% ≤ 2 years, and 22% were disabled. Mean CDAI was 7.9 (7.8). Most were in CDAI remission (n=56; 32%) or LDA (n=67; 38%); 39 (22%) were in MDA, and 14 (8%) in HDA. As compared to the general US population, patients with active RA had higher disability, fatigue, and pain; only those with HDA had elevated mood, sleep disturbance and impaired participation (Table 1). Fatigue was moderately-strongly and directly associated with pain, sleep, depression, and anxiety (r’s .45-.67), inversely to PF and participation (r=-.61 and -.64, respectively), weakly and directly with swollen joints (r=.27) and weakly and inversely with regular exercise (r=-.24)(p’s <.001). Age and RA duration were not associated with fatigue (p’s .967 and .677, respectively). VIF estimates among remaining variable ranged from 1.1–3.3. In multiple regression, pain, physical function, and anxiety were significant predictors of fatigue [F (7,157) = 28.60, p<.001, r2=.54](Table 2).

Conclusion:  In RA, fatigue is common and increases with disease activity. Pain, disability, and anxiety contributed to fatigue, whereas depression and sleep disturbance did not. Overall, anxiety was within the normal range for most (72%) except those with the high disease activity. Our data suggest that beyond pain and disability, in 28% of people with RA, anxiety may also contribute to fatigue. Stress management coaching may offer opportunities to help reduce fatigue in people whose RA is otherwise well controlled. PCORI IP2-PI0000737 and SC14-1402-10818.

Table 1. Patient reported symptoms and impacts of RA across CDAI levels (n=177).
PROMIS Measure

Remission (n=56)

Low

(n=67)

Moderate (n=39)

High

 (n=14)

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Fatigue

46.2a

8.6

55.7 b

8.3

58.5b

6.9

64.0c

9.6

Pain Interference

45.6a

7.2

56.0b

8.3

57.8b

6.1

63.4c

8.6

Physical Function

50.1a

8.8

42.2b

7.1

39.2c

5.9

32.9d

5.5

Sleep Disturbance

46.6a

8.6

53.4b,c

8.9

52.9b

10.7

58.7c

7.9

Depression

45.7a

7.9

50.1b

8.5

50.1b

8.8

56.2c

8.2

Anxiety

47.6a

7.3

52.2 b

8.5

51.3b

7.0

57.0c

7.8

Participation Social Roles/Activities

55.8a

8.3

49.1b

7.8

47.8b

6.8

38.8c

6.8

Regular Exercise

1.6a

1.1

1.2ab

1.3

0.9b

1.0

1.2ab

1.2

Different subscripts reflect significantly different groups (p<.05). Bolded values are ± .5 SD above US population norms.

Table 2. Predictors of fatigue in people with rheumatoid arthritis

Unadjusted

Adjusted*

Beta

SE

Std

Beta

t value

Sig

Beta

SE

Std

Beta

t value

Sig

Swollen Joints

.813

.274

3.746

.000

.104

.169

.035

.616

.538

Pain

.707

.059

.672

12.003

.000

.288

.092

.272

3.117

.002

PF

-.706

.065

-.635

-10.886

.000

-.242

.097

-.218

-2.505

.013

Sleep

.461

.069

.453

6.726

.000

.116

.063

.115

1.841

.068

Depression

.555

.075

.487

7.362

.000

-.049

.110

-.041

-.430

.668

Anxiety

.641

.079

.523

8.093

.000

.271

.120

.219

2.253

.026

Participation

-.676

.067

-.607

10.039

.000

-.125

.092

-.113

-1.161

.176

Exercise

-2.036

.640

-.240

-3.180

.002

-.740

.475

-.087

-1.557

.121

Std. beta = standardized estimate. *F (7,157) = 28.60, p=.000, adjusted r2=.541.


Disclosure: S. J. Bartlett, C-Path Institute, 5; M. Jones, None; C. Bingham III, C-Path Institute, 5.

To cite this abstract in AMA style:

Bartlett SJ, Jones M, Bingham C III. Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/pain-physical-function-and-worry-but-not-depression-and-poor-sleep-lead-to-greater-fatigue-in-ra/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pain-physical-function-and-worry-but-not-depression-and-poor-sleep-lead-to-greater-fatigue-in-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology